SJ Medical
SJ Medical
The global cryoablation system market has witnessed an unprecedented surge, driven by the increasing prevalence of cancer and cardiac arrhythmias. As a minimally invasive alternative to traditional surgery, cryoablation uses extreme cold (argon or liquid nitrogen) to destroy diseased tissue, offering patients faster recovery times and reduced complications. According to recent market intelligence, the industry is projected to reach a multi-billion dollar valuation by 2030, with a CAGR exceeding 10%.
When searching for a reliable Cryoablation System Manufacturer & Supplier, hospitals and distributors evaluate entities based on FDA/CE approvals, probe precision, and multi-channel control capabilities. Here are the industry leaders currently shaping the landscape:
A pioneer in cardiac cryoablation with the Arctic Front Advance™ system, dominating the AFib treatment market.
Leading the way in oncology-focused cryoablation with their Visual-Ice™ system for precise tumor destruction.
Specializing in liquid nitrogen-based ProSense™ systems for breast and kidney tumors.
Integrating cryoablation into their comprehensive radiotherapy and interventional oncology portfolio.
A rising powerhouse providing high-performance vascular and interventional access systems with global certifications.
Focusing on surgical cryoablation for complex cardiac procedures.
The remaining spots in the top 10 are held by specialized European and Asian manufacturers like Galil Medical and Healthtronics, who continue to push the boundaries of cryogenic engineering.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
The cryoablation industry is currently undergoing a massive transformation. Here are the key trends affecting global procurement and hospital demand:
In North America and Europe, cryoablation is largely used for "Office-Based Lab" (OBL) treatments of peripheral vascular disease. In Emerging Markets (Asia/LATAM), the focus is on large-scale hospital installations for liver and lung oncology, where patient volume is high.
Located in Hangzhou's medical hub, we have immediate access to high-precision components and biocompatible materials.
We can move from clinical feedback to prototype refinement in half the time of Western competitors.
Our products are CE, ISO 13485, and CFDA approved, ensuring smooth market entry in any region.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
Our products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We provide comprehensive services from pre-sales consultation to responsive after-sales support.
